Anti-Influenza B Antibody (A282825)

Anti-Influenza B Antibody

Goat polyclonal antibody to Influenza B.

This antibody recognises influenza virus type B and does not cross react with Influenza A, Para 1-3, RSV or adenovirus. It gives negative staining in indirect immunofluorescence on uninfected monkey kidney cells.Influenza virus type B is a genus in the virus family Orthomyxoviridae, responsible for acute respiratory illnesses in humans. It varies antigenically from influenza virus types A and C and is not divided into any subtypes.The gradual evolution of Influenza virus type B occurs via a series of mutations known as antigenic drift, in the surface glycoprotein haemagglutinin (HA), enabling the virus to evade the immune system and potentially re-infect the same host. HA glycoproteins from the Influenza virus type B are included in the annually updated trivalent flu vaccine, along with the Influenza virus type A subtypes H3N2 and H1N1.

WB, ELISA, IF

Viral

This antibody does not cross react with Monkey

Yamagata strain of Influenza B.

Goat

Polyclonal

IgG

5 mg/ml

Liquid

Supplied in Phosphate Buffered Saline with 0.1% Sodium Azide.

Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.

Goat anti influenza B antibody recognizes influenza virus type B and does not cross react with Influenza A, Para 1-3, RSV or adenovirus. It gives negative staining in indirect immunofluorescence on uninfected monkey kidney cells.Influenza virus type B is a genus in the virus family Orthomyxoviridae, responsible for acute respiratory illnesses in humans. It varies antigenically from influenza virus types A and C and is not divided into any subtypes.The gradual evolution of Influenza virus type B occurs via a series of mutations known as antigenic drift, in the surface glycoprotein haemagglutinin (HA), enabling the virus to evade the immune system and potentially re-infect the same host. HA glycoproteins from the Influenza virus type B are included in the annually updated trivalent flu vaccine, along with the Influenza virus type A subtypes H3N2 and H1N1.